다카라코리아바이오메디칼

Home > 전제품보기 > 세포ㆍ유전자 치료 연구 > Overview > Cancer 연구 가이드

Cancer 연구 가이드

암 연구를 위한 제품 선택가이드
Solutions for Cancer Research

암(癌, Cancer) 혹은 악성종양(惡性腫瘍, Malignant tumor, Malignant neoplasm)은 세포주기가 조절되지 않아 세포분열이 계속되는 질병으로, 폐암 · 위암 · 유방암 · 대장암 등이 있다. 암과의 싸움은 여전히 힘든 싸움으로 남아있지만, 암 연구 분야의 지속적인 발전은 큰 희망을 준다. 다카라바이오는 암 바이오마커 연구, 단일 암세포 분석, 암 후성유전인자 분석, HLA Typing, T-cell 치료 및 프로파일링, 항체치료, CRISPR/Cas9 유전자 편집 등의 암 연구를 위한 다양한 제품과 기술을 제공한다.

1. 암 바이오마커 (Cancer Biomarker Discovery)
Next Generation Sequencing (NGS) 기술의 발전에 따라 종양유전자 (oncogene), 종양억제유전자 (tumor suppressor gene)를 이용한 암 바이오마커 연구가 가속화되고 있다. 다카라바이오에서는 Liquid biopsy (Circulating tumor DNA (ctDNA), Cell-free RNA (cfRNA), Cell-free DNA (cfDNA), Urine 등), FFPE 샘플, Exosome 등에서 암 바이오마커 유전자를 검출 및 분석할 수 있는 제품을 제공한다.

1) Low input mRNA · DNA 염기서열 분석

소량의 RNA, DNA 샘플을 위한 NGS Library Preparation Kit
FFPE RNA/DNA 및 Liquid biopsy 유래의 DNA, RNA 분석 가능 (ctDNA, cfRNA, cfDNA 외)

구분	Code	제품명	특징
DNA-seq	R400679	ThruPLEX^® Plasma-Seq Kit	Cell-free DNA 분석에 최적화 Sample input: 1 ng - 30 ng of cfDNA
	R400584	ThruPLEX^® Tag-seq 6S(12)Kit	Low frequency variant 분석 16 million Unique Molecular Tags Sample input: 1 ng- 50 ng of cfDNA
	R400674	ThruPLEX^® DNA-seq Kit	Low input DNA-seq library prep Sample input: 50 pg - 50 ng of DNA
RNA-seq	634411	SMARTer^® Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian	Cell-free mRNA, lncRNA 분석 All-in-one kits for Illumina^® NGS Sample input: 250 pg - 10 ng total RNA

References
Selected publications citing the use of ThruPLEX-Plasma Seq Kit for non-invasive monitoring of tumor chemo-resistance
1. Mayrhofer, M. et al. Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis. Genome
Med. 10, 85-98 (2018).
2. Mouliere, F. et al. Detection of cell-free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients. EMBO. 12, e9323 (2018).
3. Murtaza, M. et al. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature 497, 108-112 (2013).
4. Patel, K. M. et al. Association of plasma and urinary mutant DNA with clinical outcomes in muscle invasive bladder cancer. Sci. Rep. 7, 5554 (2017).
5. Xia, Y. et al. Copy number variations in urine cell free DNA as biomarkers in advanced prostate cancer. Oncotarget 7, 35818-35831 (2016).

2) Exosomal RNA 분석

고순도의 Exosome 분리를 위한 독자적인 Capturem™ membrane spin column
Exosomal RNA 및 miRNA 분석을 위한 SMARTer^® NGS 시리즈

구분	Code	제품명	특징
Exosome 분리	635723	Capturem™ Exosome Isolation Kit (Cell Culture)	30분만에 Exosome 분리 (2x10¹¹/column) No Precipitation, No Ultracentrifugation
Exosome 분리	635741	Capturem™ Extracellular Vesicle Isolation Kit (Mini)	Liquid biopsy (plasma, saliva, CSF)로부터 Extracellular vesicle (EV) 분리
smRNA-seq	635029	SMARTer^® smRNA-Seq Kit for Illumina^®	Small RNA/MicroRNA NGS library preparation All-in-one system for Illumina^® NGS Sample input: 1 ng - 2 ㎍ of total RNA
RNA-seq	634411	SMARTer^® Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian	Exosomal mRNA, lncRNA 분석 All-in-one kits for Illumina^® NGS Sample input: 250 pg - 10 ng total RNA

References
Selected publications citing the use of SMARTer smRNA-Seq Kit for noninvasive miRNA profiling in prostate cancer diagnosis
1. Guelfi, G. et al. Next generation sequencing of urine exfoliated cells: an approach of prostate cancer microRNAs research. Sci. Rep. 8, 7111 (2018).

2. 단일 암세포 분석 (Single Cancer Cell Analysis)
종양세포에서 나타나는 복잡성 (Complexity)과 이질성 (Heterogeneity)은 종양세포 (cancer cell), 지속성 암세포 (Cancer persister cells), 순환종양세포 (Circulating Tumor Cell; CTC)를 단일세포 수준에서 해석함으로써 분석 가능하다. 그러나 단일세포를 연구하려면 아주 민감하고 재현성 높은 분석 방법이 필요하며, 다카라바이오에서는 독자적인 SMARTer^® 기술을 이용하여 단일세포 수준의 염기서열 분석을 위한 제품을 제공한다.

1) Single-cell Genome Sequencing

구분	Code	제품명	특징
WGA	R300671	PicoPLEX^® Single Cell WGA Kit	Whole Genome Amplification (WGA) Single cell CNV 분석의 Gold standard Sample input : 1 - 10 cells
DNA-seq	R300669	PicoPLEX^® Gold Single Cell DNA-Seq Kit	Single cell DNA-Seq library preparation Cancer Single cell_CNV, SNV 동시 분석 가능 Sample input: 1 - 5 cells

References
Selected publications citing the use of PicoPLEX technology for high performance CNV analysis and the genomic profiling of single cells from FFPE tumor tissues and circulating tumor cells, and G&T-seq
1. Lieselot D. et al. (2017). Performance of four modern whole genome amplification methods for copy number variant detection in single cells. Scientific Reports 7: 3422
2. Babayan A. et al. (2017). Comparative study of whole genome amplification and next generation sequencing performance of single cancer cells. Oncotarget 8: 56066-56080
3. Williamson S.C. et al. (2016). Vasculogenic mimicry in small cell lung cancer. Nature Communications 7: 13322
4. Morrow C. J. et al. (2016). Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study. Annals of Oncology 27 (6): 1155-1160
5. Premasekharan G. et al. (2016). An improved CTC isolation scheme for pairing with downstream genomics: Demonstrating clinical utility in metastatic prostate, lung and
pancreatic cancer. Cancer Letters 380 (1): 144 - 152
6. Cayrefourcq L. et al. (2015). Establishment and Characterization of a Cell Line from Human Circulating Colon Cancer Cells. Cancer Research 75 (5): 892-901
7. Macaulay I.C. et al. (2015). G&T-seq: parallel sequencing of single-cell genomes and transcriptomes. Nature Methods 12: 519-522

2) Single-cell Transcriptome Sequencing

SMART-Seq^® Technology : Single cell RNA-seq 분석의 기준
Single cell full-length cDNA 합성과 증폭

Code	제품명	특징
634470	SMART-Seq^® Single Cell Kit	Single cell로부터 고품질의 full-length cDNA 합성 RNA 함량이 낮은 세포 (e.g. PBMC)의 단일세포 분석 Sample input : Single cell, 2 pg of RNA
634888	SMART-Seq^® v4 Ultra^® Low Input RNA Kit for Sequencing	Whole Transcriptome Amplification (WTA) Sample input: 10 pg - 10 ng total RNA, 1 - 1,000 cells
634437	SMART-Seq^® HT Kit	High-throughput Single cell NGS library prep Sample input: 10 pg - 10 ng total RNA, 1 - 100 cells
634442	SMART-Seq^® Stranded Kit	Single cell Strand-specific RNA-Seq Sample input: 10 pg - 10 ng total RNA, 1-1,000 cells
635040	SMART-Seq^® v4 3' DE Kit	Single cell differential expression (DE) 적용 전용 3’-end transcript analysis Sample input: 10 pg - 10 ng Total RNA, 1-100 cells
635025	SMART-Seq^® v4 Ultra^® Low Input RNA Kit for the Fluidigm^® C1™ System	Fluidigm C1™을 이용한 Auto preparation kit Sample input: Single cell only

References
Selected publications citing the use of SMART-Seq solutions for single-cell RNA-seq in various different cancer applications
1. Chung W. et al. (2017). Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer. Nature Communications 8: 15081
2. Zheng H. et al. (2018). Single-cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma. Hepatology doi: 10.1002/hep.29778. [Epub ahead of print]
3. Kim K.T. et al. (2015). Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells. Genome Biology 16: 127
4. Han K.Y. et al. (2018). SIDR: simultaneous isolation and parallel sequencing of genomic DNA and total RNA from single cells. Genome Research 28: 75-87
5. Chiu H.S. et al. (2018). Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context. Cell Reports 23(1): 297-312

3. 암 후성유전학 (Cancer Epigenomics)
암 후성유전학 연구에서는 암 특이적 DNA-binding proteins, 히스톤 변형 (histone-modification), DNA 메틸화 (DNA methylation) 등을 분석한다. Chromatin Immunoprecipitation Sequencing (ChIP-seq) 및 최신 기술인 Cut&Run-seq은 NGS를 이용하는 후성유전학 연구 방법으로, 분석을 위해 회수되는 DNA의 양이 매우 적어 극소량의 DNA 분석을 위한 특수한 제품이 필요하다.

Code	제품명	특징
R400674	ThruPLEX^® DNA-seq Kit	ChIP-seq, Cut&Run-seq Library Preparation 3 Steps in one tube 프로토콜 (hands-on 15분) Sample input: 50 pg - 50 ng of ChIP DNA

References
Selected publications citing the use of ThruPLEX technology for whole genome sequencing, targeted sequencing, CNV analysis and ChIP-seq studies in various types of cancers
1. McNair C. et al. (2018). Differential impact of RB status on E2F1 reprogramming in human cancer. Journal of Clinical Investigation 128(1): 341-358
2. Jeselsohn R. et al. (2018). Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations. Cancer Cell 33(2): 173-186
3. Cato L. et al. (2017). Development of Bag-1L as a therapeutic target in androgen receptordependent prostate cancer. eLife 6: e27159
4. Jin X. et al. (2017). Targeting glioma stem cells through combined BMI1 and EZH2 inhibition. Nature Medicine 23(11): 1352-1361
5. Wang X. et al. (2017). Purine synthesis promotes maintenance of brain tumor initiating cells in glioma. Nature Neuroscience 20: 661-673
6. Markus H. et al. (2018). Evaluation of pre-analytical factors affecting plasma DNA analysis. Scientific Reports 8: 7375
7. Patel K.M. et al. (2017). Association of Plasma and Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer. Scientific Reports 7: 5554
8. Weiss G.J. et al. (2017). Tumor Cell-Free DNA Copy Number Instability Predicts Therapeutic Response to Immunotherapy. Clinical Cancer Research 23(17): 5074-5081
9. Klevebring D. et al. (2014). Evaluation of exome sequencing to estimate tumor burden in plasma. PLoS One 18;9(8): e104417
10. Murtaza M. et al. (2013). Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature 497: 108-112

4. 면역항암제 (Cancer Immunotherapy)
수술, 화학요법, 방사선요법과 같은 전통적인 암 치료는 암 말기 환자에게 매우 제한된 효능만을 보여주었을 뿐만 아니라, 화학요법과 방사선요법은 간혹 상당히 심각한 부작용을 일으킨다. 따라서 보다 혁신적이고 효과적인 암 치료를 위해 면역항암제가 개발되고 있으며, 이는 높은 특수성과 안전성, 낮은 부작용과 같은 장점을 가진다. 다카라바이오에서는 면역항암제 개발을 위한 다양한 연구 툴을 제공하고 있다.

1) T Cell Therapy를 위한 RetroNectin^®

T cell에 효율적인 TCR/CAR 유전자 도입을 위한 Transduction enhancer
T cell 확대배양의 효율을 증진시키는 Co-stimulator로써 적용
유전자치료 임상 실험 목적으로 전 세계 44개 기관에서 68개 이상의 프로토콜에 적용

Code	제품명	특징
T202	RetroNectin^® GMP grade (Recombinant Human Fibronectin Fragment CH-296)	Retrovirus, Lentivirus transduction enhancer Polybrene, Protamine 대비 낮은 독성 Enhanced T-cell expansion
WK552S	LymphoONE™ T-Cell Expansion Xeno-Free Medium, 1L Bottle	Serum-Free, Xeno-Free T-cell 배양 배지 T-cell의 높은 증식율 유지
T210	Anti-CD3 mAb GMP grade	GMP grade의 Anti-CD3 Monoclonal Antibody T-cell activation을 위한 stimulator

References
Selected publications citing RetroNectin GMP grade reagent use in TCR/CAR therapies
1. Kochenderfer, J. N., et al. (2012) B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-
   antigenreceptor-transduced T cells. Blood 119 (12):2709-2720
2. Robbins, P. F., et al. (2011) Tumor Regression in Patients with Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With
   NY-ESO-1. J. Clin. Oncol. 29 (7):917-924
3. Zhang, L., et al. (2013) Evaluation of γ-retroviral vectors that mediate the inducible expression of IL-12 for clinical application. J. Immunother. 35(5):430-439
4. Brentjens, R., et al. (2013) CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia.
   Science Translational Medicine 5 (177):177ra38
5. Ramos C. A. et al. (2017). Clinical and Immunological Responses after CD30-Specific Chimeric Antigen Receptor-Redirected Lymphocytes. The Journal of Clinical
   Investigation 127 (9): 3462-71
6. Tang X.Y. et al. (2016). Third-Generation CD28/4-1BB Chimeric Antigen Receptor T Cells for Chemotherapy Relapsed or Refractory Acute Lymphoblastic Leukaemia:
   A NonRandomised, Open-Label Phase I Trial Protocol. BMJ Open 6 (12)
7. Ali S.A. et al. (2016). T Cells Expressing an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Multiple Myeloma. Blood 128 (13): 1688-1700
8. Stroncek D.F. et al. (2016). Myeloid Cells in Peripheral Blood Mononuclear Cell Concentrates Inhibit the Expansion of Chimeric Antigen Receptor T Cells.
   Cytotherapy 18 (7): 893-901
9. Tomuleasa C. et al. (2018). Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia. Frontiers in Immunology: 19 February

2) TCR, BCR Profiling 분석을 위한 SMARTer^® Immune Profiling Kits

5’ RACE (Rapid Amplification cDNA Ends)와 NGS 기술의 조합으로 보다 간편하고 강력한 Profiling
TCRα, TCRβ chain 또는 BCR Heavy chain (H), Kappa chain (κ), Lamda chain (λ) 개별 또는 동시 분석

구분	Code	제품명	특징
TCR	635014	SMARTer^® Human TCR a/b Profiling Kit	Human Bulk TCR 분석 Sample input: 10 ng - 3 ㎍ Human blood RNA, 50 - 10,000 lymphocytes
	634431	SMARTer^® Human scTCR a/b Profiling Kit	Human single cell TCR 분석
	634402	SMARTer^® Mouse TCR a/b Profiling Kit	Mouse Bulk TCR 분석 Sample input: 10 ng - 500 ng total RNA 또는 1,000 - 10,000개의 purified T-cell
	640182	ICELL8^® Human TCR a/b Profiling Reagent Kit	ICELL8^® cx Single-Cell System로 분리한 Single cell로부터 TCR Profiling
BCR	634466	SMARTer^® Human BCR IgG IgM H/K/L Profiling Kit	Human Bulk BCR 분석 UMI based correction 적용으로 정확한 분석 Sample input: 10 ng - 1 ㎍ of PBMC RNA 또는 1 - 100 ng of B cell RNA
BCR	634422	SMARTer^® Mouse BCR IgG H/K/L Profiling Kit	Mouse Bulk BCR 분석 Sample input: 10 ng - 3 ㎍ total RNA

3) Antibody Therapeutics

Monoclonal antibody, Antibody drug conjugates (ADC) 항체의약품, 치료제 연구
Construct 제작부터 정제, 분석을 위한 제품

구분	Code	제품명	특징
Expression construct 제작	639648	In-Fusion^® HD Cloning Kit	Antibody expression construct 제작을 위한 High-throughput cloning Fast (15 min), Efficient (>95%), Seamless
His-tag 단백질 정제	635710	Capturem™ His-Tagged Purification Miniprep Kit	His-tagged 단백질 정제 실온에서 5 ~ 15분이면 고순도 단백질 정제
Biotin-tag 단백질 정제	635733	Capturem™ Streptavidin Miniprep Columns	Biotinylated 단백질 정제
항체 정제 IP	635717	Capturem™ Protein A Miniprep	Protein A를 이용한 고순도 항체 정제
	635725	Capturem™ Protein G Miniprep	Protein G를 이용한 고순도 항체 정제
	635721	Capturem™ IP & Co-IP Kit	Protein A를 이용하여 IP & Co-IP를 15분만에
MS 분석 샘플 전처리	635740	Capturem™ Trypsin Miniprep Kit (Mass Spectrometry Grade)	단 4분, Trypsin digestion Autolysis 최소화
MS 분석 샘플 전처리	635728	Capturem™ Pepsin	단 3분, Pepsin digestion

References
Selected publications citing the use of In-Fusion HD Cloning for HTP antibody cloning
1. Spidel J.L. et al. (2016). Rapid high-throughput cloning and stable expression of antibodies in HEK293 cells. Journal of Immunological Methods 439: 50-58
2. Chen C.G. et al. (2014). One-step zero-background IgG reformatting of phage-displayed antibody fragments enabling rapid and high-throughput lead identification.
Nucleic Acids Research 42 (4): e26
3. Meng W et al. (2015). Efficient generation of monoclonal antibodies from single rhesus macaque antibody secreting cells. mAbs 7 (4): 707-718

5. HLA Typing
Human Leukocyte Antigen (HLA)는 매우 다형성이 높은 영역 (highly polymorphic region)으로, 면역 조절에 관련된 여러 개의 유전자로 구성되어있다. HLA Typing 기법은 암 발병기전과 관련된 반복적인 돌연변이 (target recurrent mutation)와 핫스팟 (hotspot site)을 연구하는 아주 중요한 분석 방법이다. HLA Typing을 위한 NGS는 복잡한 DNA 주형을 광범위하게 분석하기 위하여 높은 특이성과 정확성을 요구한다. 다카라바이오는 Targeted sequencing을 위한 high-fidelity polymerase와 NGS Library preparation kit를 제공한다.

1) Targeted sequencing을 위한 High-fidelity PCR Polymerase

Targeted Sequencing (NGS, Sanger)을 위한 Target amplification에 최적
매우 높은 정확도로 GC 함량이 높은 long fragment target 증폭 (>30 kb)

Code	제품명	특징
R050A	PrimeSTAR^® GXL DNA Polymerase	GC-rich, long fragment target 증폭에 최적 3’ → 5’ exonuclease 활성으로 에러율 최소화
R051A	PrimeSTAR^® GXL Premix	Premix type의 PrimeSTAR^® GXL DNA Polymerase

References
Selected publications citing the use of PrimeSTAR GXL and/or TaKaRa LA Taq enzymes for HLA Typing
1. Liu C. et al. (2018). Accurate Typing of Human Leukocyte Antigen Class I Genes by Oxford Nanopore Sequencing. Journal of Molecular Diagnostics 2: 006
2. Xu Y.-P. et al. (2017). A novel HLA-E allele, HLA-E*01:01:01:06, identified in a Chinese Leukemia patient. HLA 89: 260-262
3. Yin Y. et al. (2016). Application of High-Throughput Next-Generation Sequencing for HLA Typing on Buccal Extracted DNA: Results from over 10,000 Donor Recruitment
   Samples. PLOS ONE 11(10): e0165810.
4. Mayor N.P. et al. (2015). HLA Typing for the Next Generation. PLOS ONE 10 (5): e0127153.
5. Lan, J. H. et al. (2015). Impact of Three Illumina Library Construction Methods on GC Bias and HLA Genotype Calling. Human Immunology 76(2-3), 166-175
6. Ozaki Y. et al. (2015). Cost-efficient multiplex PCR for routine genotyping of up to nine classical HLA loci in a single analytical run of multiple samples by next
   generation sequencing. BMC Genomics 16:318
7. Ozaki Y. et al. (2013). HLA-DRB1, -DRB3, -DRB4 and -DRB5 genotyping at a super-high resolution level by long range PCR and high-throughput sequencing.
   Tissue Antigens 83: 10-16

2) HLA Typing을 위한 Whole Genome Amplification (WGA)

Code	제품명	특징
R300671	PicoPLEX^® Single Cell WGA Kit	NGS, Sanger, Array를 이용한 HLA typing을 위한 WGA Sample input : 1 - 10 cells
R300669	PicoPLEX^® Gold Single Cell DNA-Seq Kit	NGS Library Preparation for HLA Typing Sample input: 1 - 5 cells

References
Selected publications citing the use of SMARTer PicoPLEX technology for HLA Typing
1. Murphy N.M. et al. (2016). Haplotyping the human leukocyte antigen system from single chromosomes. Scientific Reports 6: 30381
2. Png E. et al. (2011) A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants
in the HLA region. Human Molecular Genetics 20 (19): 3893-3898

6. Gene Editing for Cancer Therapy & Drug Discovery
CRISPR/Cas9 유전자 편집 기술은 기존의 ZFN, TALEN 유전자 편집에 비해 보다 효율적으로 유전자 편집을 수행할 수 있으며, 어떠한 유기체에서도 표적특이적인 유전자 편집 (Site-specific genomic targeting & editing)을 할 수 있다. 암 연구에서 CRISPR/Cas9 유전자 편집 기술은 종양유전자의 메커니즘 분석, 항암제 개발의 대상 유전자 동정, 세포 기반 치료의 암세포 식별 등 다양하게 적용 가능하다. 다카라바이오에서는 CRISPR/Cas9 Gene Editing을 위한 Guide-it™ 시리즈를 제공하고 있다.

구분	Code	제품명	특징
Drug target 분석	632646	Guide-it™ CRISPR Genome-Wide sgRNA Library System	Brunello library 기반의 76,000개의 sgRNA library 4 sgRNAs per gene, 19,114 genes targeted
sgRNA 합성	632636	Guide-it™ Complete sgRNA Screening System	In vitro transcription 방법의 sgRNA 합성 12 ㎍ 이상의 고품질 sgRNA 제작 가능 sgRNA candidates 효율 검증을 위한 스크리닝
Knock-in template	632644	Guide-it™ Long ssDNA Production System	Knock-in 목적의 ssDNA HDR Donor Template 제작 Long ssDNA template 합성 가능 (~ 5 kb)
WT Cas9	632641	Guide-it™ Recombinant Cas9 (Electroporation-Ready)	Wild type spCas9 Low glycerol 농도로 낮은 세포 독성 높은 편집 효율
K/O 확인	631448	Guide-it™ Mutation Detection Kit	T7E1, CEL1 Assay보다 명확한 Knock-out 검출
K/I 확인	632659	Guide-it™ Knockin Screening Kit	SNP, Knock-in gene 도입 검출

* Guide-it™ CRISPR/Cas9 전 제품은 여기를 확인하세요.

References
Selected publications citing the use of various Guide-it CRISPR/Cas9 kits for different cancer applications
1. Lao Y.H. et al. (2018). HPV Oncogene Manipulation Using Nonvirally Delivered CRISPR/Cas9 or Natronobacterium gregoryi Argonaute. Advanced Science: 1700540
2. Kagoya Y. et al. (2018). DOT1L inhibition attenuates graft-versus-host disease by allogeneic T cells in adoptive immunotherapy models. Nature Communications 9: 1915